View More Recent Stories

Mar 24, 2025 08:38AM Genmab (GMAB) to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc. (ABBV)

Mar 17, 2025 12:19PM Genmab A/S (GMAB) Reports Rina-S Continues to Show Encouraging Antitumor Activity in Patients with Advanced Ovarian Cancer

Mar 11, 2025 09:16AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK2,300 at RBC Capital

Mar 11, 2025 06:04AM Genmab A/S (GEN:DC) (GMAB) PT Lowered to DKK1,900 at Deutsche Bank

Mar 11, 2025 01:11AM William Blair Upgrades Genmab A/S (GMAB) to Outperform

Mar 10, 2025 03:12PM Genmab A/S (GMAB) PT Lowered to $45 at Truist Securities

Mar 10, 2025 10:14AM Genmab A/S (GMAB): J&J will not exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38

Feb 13, 2025 07:17AM Truist Securities Reiterates Buy Rating on Genmab A/S (GMAB)

Feb 13, 2025 06:20AM Leerink Partners Upgrades Genmab A/S (GMAB) to Outperform

Feb 11, 2025 02:52AM BNP Paribas Exane Upgrades Genmab A/S (GEN:DC) (GMAB) to Neutral

Jan 22, 2025 06:26AM Genmab A/S (GMAB) Reports 2024 Net Sales of DARZALEX of $11.67B

Jan 8, 2025 09:27AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Dec 21, 2024 10:00AM RBC report: Biotech faces both uncertainty and growth opportunities in 2025

Nov 7, 2024 09:17AM Genmab A/S (GMAB) PT Raised to $48 at BMO Capital

Nov 7, 2024 05:56AM Genmab A/S (GMAB) PT Lowered to $27 at Leerink Partners

Oct 16, 2024 06:53AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Oct 15, 2024 06:28AM Genmab A/S (GMAB) Reports Q3 Net sales of DARZALEX of $3.01B

Oct 11, 2024 08:46AM TD Cowen Reiterates Hold Rating on Genmab A/S (GMAB)

Oct 8, 2024 04:09AM Redburn-Atlantic Starts Genmab A/S (GEN:DC) (GMAB) at Buy

Sep 20, 2024 06:48AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Sep 16, 2024 06:59AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Sep 13, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Sep 9, 2024 06:55AM Genmab A/S (GMAB) PT Lowered to $50 at Truist Securities

Sep 4, 2024 01:56AM Morgan Stanley Resumes Genmab A/S (GMAB) at Equalweight

Aug 19, 2024 11:42PM JPMorgan Downgrades Genmab A/S (GEN:DC) (GMAB) to Neutral

Aug 19, 2024 02:01PM Genmab A/S (GMAB) Receives Second EU Approval for TEPKINLY

Aug 9, 2024 10:22AM Genmab A/S (GMAB) PT Lowered to $30 at TD Cowen

Aug 9, 2024 08:04AM Genmab A/S (GMAB) PT Lowered to $46 at BMO Capital

Aug 8, 2024 11:01AM Genmab (GMAB) Updates 2024 Financial Guidance

Jul 19, 2024 09:58AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Jul 17, 2024 06:27AM Genmab A/S (GMAB) Reports Q2 New DARZALEX Sales of $2.88B

Jul 15, 2024 02:42AM RBC Capital Upgrades Genmab A/S (GEN:DC) (GMAB) to Outperform

Jun 28, 2024 05:49AM Genmab A/S (GMAB) Reports Positive CHMP Opinion for Epcoritamab

Jun 27, 2024 06:37AM H.C. Wainwright Reiterates Buy Rating on Genmab A/S (GMAB)

Jun 27, 2024 05:08AM Genmab A/S (GMAB) PT Raised to $47 at BTIG

Jun 24, 2024 09:58AM Genmab A/S (GMAB) provides update on share buyback

View More Recent Stories